The ultimate transparency suite™
TrialAssure® is a global clinical trial transparency suite with unmatched experience in helping clients navigate complex regulatory submission and reporting challenges. TrialAssure helps meet regulatory compliance goals through a flexible, scalable, and streamlined platform that supports trial registration, disclosure, data sharing, anonymization, and plain language summary activities.
Built by transparency experts for pharmaceutical professionals
TrialAssure was built from the ground up as a single, integrated transparency system, and it is continually strengthened by the experience of leading pharmaceutical industry compliance experts.
- Developed and supported by experts with extensive experience in navigating the complex path of disclosure compliance
- Flexible and scalable solution that adapts to your needs and keeps pace with global changes in compliance and reporting requirements
- Seamlessly integrates with outside systems to help clients leverage existing data, gain efficiencies, and improve reporting accuracy
Latest TrialAssure News
Former Gilead Sciences Head of Clinical Trial Disclosure and Data Transparency Joins TrialAssure as Director, Global Transparency Strategy & Compliance
Bringing more than 20 years of experience, Kelly Vaillant has led functions across clinical development at Gilead, Ambit Biosciences, Novartis, Amgen, and Pharmacia. An innovator in the Clinical Trial Disclosure and Data Transparency space, he has developed and implemented processes, technologies, and systems that enable more effective, efficient, and secure sharing of clinical trial information.
License TrialAssure™, the comprehensive transparency management system, as a Software-as-a-Service solution to help your organization manage your study pipeline.
Leverage disclosure expertise to provide full transparency management for your organization to guarantee complete accuracy and global compliance.
Use Summary Writing and Quality experts to assist with disclosure activities when your central team needs it most.